Newgenivf Group Cl A (NIVF)

$0.35 -0.01 (-2.59%)
Market Cap 1.85M
Revenue (ttm) 5.14M
Net Income (ttm) 130,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 2.53%
Debt to Equity Ratio 0.00
Volume 348,500
Avg Vol 3,553,350
Day's Range N/A - N/A
Shares Out 5.27M
Stochastic %K 57%
Beta 0.18
Analysts Strong Buy
Price Target N/A

Latest News on NIVF

NewGen Filed 2024 Annual Report on Form 20-F

Apr 22, 2025, 9:26 AM EDT - 5 days ago

NewGen Filed 2024 Annual Report on Form 20-F

NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth

Apr 3, 2025, 8:30 AM EDT - 25 days ago

NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet

Mar 31, 2025, 11:51 AM EDT - 27 days ago

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet

NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness

Mar 31, 2025, 9:09 AM EDT - 27 days ago

NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness

NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology

Mar 7, 2025, 11:30 AM EST - 7 weeks ago

NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology

NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan

Mar 3, 2025, 7:00 AM EST - 2 months ago

NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan

NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market

Feb 28, 2025, 7:00 AM EST - 2 months ago

NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market

NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025

Feb 20, 2025, 4:30 PM EST - 2 months ago

NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025

NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

Feb 20, 2025, 6:00 AM EST - 2 months ago

NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

NewGen Announces Reverse Stock Split

Jan 31, 2025, 8:00 AM EST - 3 months ago

NewGen Announces Reverse Stock Split

NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology

Jan 21, 2025, 6:00 AM EST - 3 months ago

NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology

NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia

Jan 13, 2025, 6:00 AM EST - 3 months ago

NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia

NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline

Dec 23, 2024, 7:30 AM EST - 4 months ago

NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline

NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance

Nov 22, 2024, 7:00 AM EST - 5 months ago

NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance

NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price

Oct 14, 2024, 8:00 AM EDT - 7 months ago

NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price

NewGenIvf Announces Filing of 2023 Annual Report with the SEC

Aug 21, 2024, 7:00 AM EDT - 8 months ago

NewGenIvf Announces Filing of 2023 Annual Report with the SEC

NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX

Jul 23, 2024, 4:30 PM EDT - 9 months ago

NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX

NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities

May 28, 2024, 8:30 AM EDT - 11 months ago

NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

Apr 22, 2024, 9:00 AM EDT - 1 year ago

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

NewGenIvf and A SPAC I Announce Closing of Business Combination

Apr 3, 2024, 4:30 PM EDT - 1 year ago

NewGenIvf and A SPAC I Announce Closing of Business Combination

NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination

Mar 5, 2024, 7:30 AM EST - 1 year ago

NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination

NewGenIvf, a full-service fertility services provider in Asia, Announces Plans to List on Nasdaq Through Merger with A SPAC I Acquisition Corp.

Feb 16, 2023, 5:25 PM EST - 2 years ago

NewGenIvf, a full-service fertility services provider in Asia, Announces Plans to List on Nasdaq Through Merger with A SPAC I Acquisition Corp.